HOME >> BIOLOGY >> TECHNOLOGY |
Hot Start DNA polymerases have become very popular because of their convenience and their ability to reduce nonspecific amplification. Typical Hot Start enzymes utilize chemical or antibody mediated inhibition, which impart disadvantages such as a long initial denaturing step or excessive protein contamination. In contrast, Eppendorfs HotMaster uses an innovative temperature-dependent inhibitor to achieve Hot Start activity. In addition to increasing specificity and sensitivity in PCR reactions, HotMaster offers several advantages not available in other Hot Start DNA polymerases: the Mg++ concentration is pre-optimized and self adjusting; no heat activation step is required, the polymerase is inhibited in a temperature-dependent manner during each annealing step of the PCR (at temperatures below ~60C); and larger target sizes can be amplified.
Introduction
Hot Start PCR was developed as a method to minimize the deleterious effects
of mispriming at lower temperatures during PCR. In a PCR reaction, even
short incubations at temperatures below the optimum annealing temperature
for a particular set of primers can result in mispriming, elongation and
the subsequent formation of spurious bands. The Hot Start technique involves
inactivating (or leaving out) one critical component of the PCR reaction
until the temperature has risen above this optimal annealing temperature.
Most Hot Start kits on the market today
rely on chemical modification
or antibodies to inhibit Taq polymerase; thus, their action is limited
to the first cycle of the PCR reaction. In addition, they impart some
disadvantages such as long pre-incubations at high temperatures
or protein contamination.
Eppendorf has developed an innovative Hot Start technology. This new technology uses a ligand that binds to the Taq polymerase in a temperature-dependent manner and inhibits it. This ligand is thermostable, and it is active in all cycles of the PCR. The net result is that Eppendorf's HotMaster kit not only offers Hot Start activity during the first cycle of the PCR, but also Cold Stop activity at temperatures below 60C during the annealing step of each and every cycle of the PCR.
The buffer is formulated to adjust the Mg++ concentration automatically so that there is never a need for optimization of this critical component. It does this by weakly chelating Mg++ ions: when Mg++ is present in excess, it is bound by the chelating agent, but as it is needed by the reaction (for Taq or DNA), it is released. This is an innovative technology that further improves the sensitivity and specificity of HotMaster.
The series of experiments in this paper were designed to show that Eppendorf Hot Start/Cold Stop and self-adjusting Mg++ technology offer a superior alternative to other Hot Start Taq polymerases. It increases specificity as well as the length of the product that is amplified relative to other Hot Start polymerases. Eppendorf's HotMaster also gives increased sensitivity: we were able to reproducibly amplify a single-copy gene from as little as 10 pg of human genomic DNA (about 2 genomic equival ents).
Materials and methods
All PCR reactions were performed in triplicate on the Eppendorf Mastercycler gradient using human genomic DNA or Phage Lambda DNA (New England BioLabs, USA) as indicated. The reaction components are:
1x PCR buffer
2.5 mM Mg++
0.2 M of each primer
0.2 mM dNTP's
1.25 units respective Taq polymerase
MBGW to 50 l total reaction volume
(Templates are indicated in each experiment)
Note that we have determined empirically that the optimal temperature for the elongation step using HotMaster is 65C.
Experiment 1: Specificity
A 131 bp target in the human TNF gene was amplified using Eppendorf HotMaster Taq DNA polymerase, a conventional chemically modified Hot Start DNA polymerase, an antibody- mediated Hot Start DNA polymerase and standard Taq DNA polymerase. The following reaction conditions were used:
Primers and Template:
Primers 131 bp TNF system
Forward Primer: GGTTTCGAAGTGGTGGTCTTG
Reverse Primer: CCTGCCCCAATCCCTTTATT
Template: 50 ng human gDNA
A 5.0 kb Phage Lambda target was amplified using Eppendorf HotMaster Taq DNA polymerase and Competitor A Hot Start DNA polymerase.
Primers and template:
Forward Primer: GGCAAGCATAAGCACACAGA
Reverse Primer: CAGCATAAGCGGCTACATGA
Template: 10 ng Lambda DNA
A 201 bp target in the human SRY gene (a single copy gene on the Y chromosome) was amplified using Eppendorf HotMaster Taq DNA polymerase.
Primers and template:
Forward Primer: CTCCGGAGAAGCTCTTCCTT
Reverse Primer: CAGCTGCTTGCTGATCTCTG
Template: 0 pg-100 ng human male DNA
Results and Discussion
Specificity
In order to determine the performance of the HotMaster Taq polymerase versus other Hot Start systems, we chose a set of primers that normally gives multiple nonspecific bands. When these primers were used to amplify a 131 bp fragment of the human TNF target, HotMaster Taq (Fig. 1, lanes 4-6) clearly outperformed the chemically modified Hot Start enzyme (Fig. 1, lanes 7-8) and the antibody-inhibited Hot Start enzyme (Fig. 1, lanes 10-11). Though the chemically modified Hot Start enzyme gave expected bands, the yield of the reaction is significantly lower than that of Eppendorf HotMaster. The low yield is probably caused by the partial loss of enzymatic activity during the long initial denaturation step at high temperature (95C for 10 minutes). The yield for the antibody- blocked Hot Start enzyme is comparable to that of the regular Taq polymerase. However, the nonspecific bands were produced presumably because the antibody had been denatured in the early cycles and was no longer able to provide inhibition of the polymerase at sub-optimal annealing temperatures. As expected, HotMaster produces a greater yield and more specific amplification than standard Taq (Fig. 1, lanes 1-3).
Figure 1: Amplification of a 131 bp fragment of the human TNF gene using
HotMaster and competing Hot Start technologies.
Lanes 1-3: Standard Taq
Lanes 4-6: Eppendorf HotMaster Taq
Lanes 7-9: Chemically blocked Taq
Lanes 10-12: Antibody-blocked Taq
M: 100 bp ladder (NEB)
Processivity:
HotMaster Taq can be used to amplify fragments up to 5.0 kb long. HotMaster
easily amplifies a 5.0 kb fragment from Lambda Phage. In contrast, a chemically
modified Hot Start enzyme barely produces any amplification of this same
fragment (Fig. 2).
Figure 2: Amplification of a 5.0 kb Lambda DNA target using Eppendorf
HotMaster Taq and Competitor A Hot Start Taq.
1 l of the PCR reactions was loaded onto a 1% agarose gel. Replicates
are shown for each enzyme.
Sensitivity
To test the limits of the amount of template that can be amplified in
a highly complex background, a fragment of the male-specific human single-copy
gene SRY was amplified using HotMaster Taq. Based on the knowledge that
6 pg of human gDNA equals one copy of the genome, serial dilutions of
male DNA were spiked into a constant background of 100 ng female DNA so
that the PCR reactions contained 0, <10, 10, 100, 1,000 or 10,000 copies
of the target gene.The data show (Fig. 3) that HotMaster Taq DNA Polymerase
is able to amplify even extremely low (<10) target DNA molecules in
a high background of non-specific DNA.
Conclusions
Eppendorf HotMaster Taq DNA Polymerase offers several advantages over other Hot Start DNA polymerases. First and foremost, HotMaster Taq both reduces non-specific PCR products and increases specific yield to a greater extent than the major Hot Start DNA polymerases on the market. This is primarily due to the significant advantages of this kit such as Hot Start/Cold Stop technology. In addition, no heat activation is required with HotMaster, and target sizes of up to 5.0 kb can be efficiently and reproducibly amplified. Furthermore, the Mg++ concentration is self-adjusting, which makes it optimal for virtually all targets. Lastly, because of its unique technology, HotMaster will not contaminate PCR reactions with unwanted proteins as do the Hot Start DNA polymerases that employ antibodies to achieve inhibition. Testing has also shown that HotMaster Taq can be used in real time PCR applications (data not shown).
*This product is sold under licensing arrangements with F. Hoffmann-La
Roche Ltd., Roche Molecular Systems, Inc., and Applied Biosystems.